Citigroup Inc Sight Sciences, Inc. Transaction History

Citigroup Inc

$150 Billion
Q1 2024

A detailed history of Citigroup Inc transactions in Sight Sciences, Inc. stock. As of the latest transaction made, Citigroup Inc holds 3,755 shares of SGHT stock, worth $23,243. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,755

Previous 3,278 14.55%

Holding current value

$23,243

Previous $16,000 18.75%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$4.02 - $5.89 $1,917 - $2,809	477 Added 14.55%	3,755 $19,000
Q4 2023 Feb 09, 2024	BUY	$1.29 - $5.86 $4,046 - $18,382	3,137 Added 2224.82%	3,278 $16,000
Q3 2023 Nov 09, 2023	SELL	$2.88 - $8.8 $22,466 - $68,648	-7,801 Reduced 98.22%	141 $0
Q2 2023 Aug 10, 2023	BUY	$7.46 - $10.67 $46,475 - $66,474	6,230 Added 363.9%	7,942 $65,000
Q1 2023 May 11, 2023	BUY	$8.44 - $13.35 $5,376 - $8,503	637 Added 59.26%	1,712 $14,000

Q4 2022 Feb 09, 2023	BUY	$5.58 - $13.94 $3,805 - $9,507	682 Added 173.54%	1,075 $13,000
Q3 2022 Nov 10, 2022	SELL	$6.1 - $11.41 $7,521 - $14,068	-1,233 Reduced 75.83%	393 $2,000
Q2 2022 Aug 10, 2022	SELL	$6.61 - $11.99 $29,216 - $52,995	-4,420 Reduced 73.11%	1,626 $14,000
Q1 2022 May 12, 2022	SELL	$11.56 - $17.9 $48,875 - $75,681	-4,228 Reduced 41.15%	6,046 $70,000
Q4 2021 Feb 10, 2022	BUY	$17.36 - $27.36 $123,446 - $194,556	7,111 Added 224.82%	10,274 $181,000
Q3 2021 Nov 10, 2021	BUY	$22.34 - $39.1 $70,661 - $123,673	3,163 New	3,163 $72,000

Others Institutions Holding SGHT

# of Institutions

Shares Held

21.1M

Call Options Held

33.2K

Put Options Held

27.7K

View Full List

About Sight Sciences, Inc.

Ticker SGHT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,826,200
Market Cap $296M
Description
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...

More about SGHT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account